Open Access. Powered by Scholars. Published by Universities.®
- Discipline
Articles 1 - 2 of 2
Full-Text Articles in Entire DC Network
Sleep Disturbance In Men Receiving Androgen Deprivation Therapy For Prostate Cancer: The Role Of Hot Flashes And Nocturia, Brian D. Gonzalez, Brent J. Small, Mallory G. Cases, Noelle L. Williams, Mayer N. Fishman, Paul B. Jacobsen, Heather S. L. Jim
Sleep Disturbance In Men Receiving Androgen Deprivation Therapy For Prostate Cancer: The Role Of Hot Flashes And Nocturia, Brian D. Gonzalez, Brent J. Small, Mallory G. Cases, Noelle L. Williams, Mayer N. Fishman, Paul B. Jacobsen, Heather S. L. Jim
Aging Studies Faculty Publications
Background: Patients with prostate cancer receiving androgen deprivation therapy (ADT) are at risk of sleep disturbance; however, to the authors' knowledge, the mechanisms by which ADT may affect sleep are not well understood. The current study compared objective and subjective sleep disturbance in ADT recipients and controls and examined whether sleep disturbance in ADT recipients is attributable to the influence of ADT on hot flashes and nocturia.
Methods: Patients with prostate cancer were assessed before or within 1 month after the initiation of ADT as well as 6 months and 12 months later (78 patients). Patients with prostate cancer were …
Characteristics And Predictors Of Fatigue Among Men Receiving Androgen Deprivation Therapy For Prostate Cancer: A Controlled Comparison, Ashley M. Nelson, Brian D. Gonzalez, Heather S.L. Jim, Julie M. Cessna, Steven K. Sutton, Brent J. Small, Mayer N. Fishman, Babu Zachariah, Paul B. Jacobsen
Characteristics And Predictors Of Fatigue Among Men Receiving Androgen Deprivation Therapy For Prostate Cancer: A Controlled Comparison, Ashley M. Nelson, Brian D. Gonzalez, Heather S.L. Jim, Julie M. Cessna, Steven K. Sutton, Brent J. Small, Mayer N. Fishman, Babu Zachariah, Paul B. Jacobsen
Aging Studies Faculty Publications
Purpose: Although fatigue is a common problem for men with prostate cancer undergoing androgen deprivation therapy (ADT), there has been little systematic research on this issue. The present study examined changes in fatigue among prostate cancer patients receiving ADT compared to controls and predictors of heightened fatigue in ADT patients.
Methods: Prostate cancer patients treated with ADT (ADT+ group, n = 60) completed assessments of fatigue prior to or just after ADT initiation (baseline) and 6 and 12 months later. Prostate cancer patients treated with prostatectomy only (ADT- group, n = 85) and men without cancer (CA- group, n = …